12 escaños

La derecha consigue frenar al independentismo catalán en Andalucía buff.ly/2G4M5a2

RT si quieres #PizzaGratis 😎 #TelepizzaDe1Metro

⚠️Recordatorio⚠️ Este miercoles a las 13:00h nos reunimos en el IRB Lleida para organizarnos y seguir trabajando para preparar la #huelga del #28M. No podéis fallar! Por la aprobación del EPIF, por nuestros derechos! Juntas/os somos más fuertes!

Se acerca la Declaración de la Renta. No olvides marcar la X en la casilla de la Iglesia. Recuerda que son nuestros rezos y no los científicos y sanitarios quienes te curan.

#SinCienciaNoHayFuturo Nunca 5 palabras han significado tanto a dia de hoy. Una frase que contiene 2 palabras tan bonitas: Ciencia y Futuro. Tan llenas de esperanza. Pero les añades Sin y No (y el necesario verbo) y de repente: tristeza, escalofríos, indignación. ¿Qué sientes tú?

Today we celebrate #WorldCancerDay @CIBERONC! At the Oncological Pathology group we do basic, translational and clinical research to find new therapeutic strategies to fight against #endometrial_cancer CIBER ISCIII IRBLleida IDIBELL Xavier Matias-Guiu G Hospital Universitari Arnau de Vilanova Núria Eritja

We are the Oncological pathology group at Fundació Roc Pifarre instagram.com/p/CNUNoY7BZw3/…

Espectacular primer concierto post pandemia!!! Y aún más espectacular La M.O.D.A. 𐁇 ... Sin palabras😍 #fmlleida Raúl Navaridas

After much effort, happy to share our latest work on the role of ARID1A in the acquisition of more aggressive endometrial cancers!!! Molecular Oncology SWI/SNF 🔬🧫🧪 febs.onlinelibrary.wiley.com/doi/full/10.10…

Supported by Stand Up To Cancer, a new multi-institutional team of gastroesophageal experts, led by HICCC director Anil K. Rustgi, MD, will focus on investigating innovative and effective immunotherapies for esophageal squamous cell cancer. cancer.columbia.edu/news/new-2-5m-…

The results of a study in nature identify netrin-1 blockade as a clinical strategy triggering both tumour debulking and EMT inhibition, thus potentially alleviating resistance to standard endometrial cancer treatments. go.nature.com/3OF2JOQ

Delighted to share our new publication in @nature describing the first pharmacological approach that targets EMT, decreases metastasis and sensitizes cancer cells to chemotherapy in preclinical models of tumor with EMT nature.com/articles/s4158…

Congratulations to the first authors Justine Lengrand, Ievgenia Pastushenko and Sebastiaan (Seb) Vanuytven and all our colleagues for their fantastic job. Thanks to Patrick Mehlen and our collaborators from Netris Pharma that developed the antibody targeting Netrin-1 nature.com/articles/s4158…

In a companion paper @nature, we show that administration of the antibody against Netrin-1 inhibits EMT in patients with endometrial cancers. Great to see our basic discovery translates into a therapy that can be used to target EMT in cancer patients nature.com/articles/s4158…

Hope that this new approach targeting EMT will now be helpful for the treatment of patients with cancers. Congratulations to our collaborators from the University of Lyon and Netris Pharma. Thanks to all our colleagues that contributed to this work. nature.com/articles/s4158…

Nature research paper: Netrin-1 blockade inhibits tumour growth and EMT features in endometrial cancer go.nature.com/45dpfDU

Very glad and proud of our last paper published in nature, as a result of a nice collaboration with #NetrisPharma and #CentreLeonBerard. Thanks to all the collaborators! IRBLleida-IDIBELL precision therapies IRBLleida

“...si yo muero antes que tú, Creo que no voy a extrañar al cielo... Ser tu amigo, Ya era Un pedazo de Cielo” A I.M.E.